Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 44.5 | 48 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 55.0 | 45 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 45.0 | 44 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 65.0 | 39 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 79.0 | 45 | |
RA1869 | TNF-a | 100 | ng/mL | 1 | LIF | 80.0 | 46 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 69.0 | 38 | |
N2759 | TNF-a | 100 | ng/mL | 1 | LIF | 66.0 | 59 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 65.0 | 43 | |
RA1931 | TNF-a | 100 | ng/mL | 1 | LIF | 75.0 | 51 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | LIF | 66.0 | 34 | |
N2586 | TNF-a | 100 | ng/mL | 1 | LIF | 75.0 | 39 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 116.0 | 33 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 131.0 | 39 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 124.0 | 43 | |
N2759 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 132.0 | 33 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 127.5 | 46 | |
RA1931 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 129.0 | 40 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 122.5 | 46 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 130.0 | 49 | |
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 217.0 | 36 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 1 | LIF | 225.0 | 48 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 192.0 | 43 | |
N2759 | IL-1 alpha | 100 | ng/mL | 1 | LIF | 211.0 | 46 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | LIF | 283.0 | 35 |